Field notes
The sovereign-grade bioeconomy, in writing.
Essays from BioGrowth on capital, regulation, and commercialization — for founders, scientists, and investors operating at institutional standards.
What sovereign-wealth-grade actually means for the bioeconomy
Institutional discipline — not marketing polish — is what separates the next wave of biotech infrastructure from the last cycle of pitch-deck platforms.
Jun 18, 2026· 7 minGrant matching that actually closes: designing for the 5% hit rate
Most grant tools optimize for volume of matches. The only metric that matters is award rate. Here is how BioGrowth is engineered around it.
Jun 2, 2026· 6 minFrom discovery to commercialization, in one place
Fragmentation is the tax the bioeconomy pays every day. A single, connected surface — from paper to product — is worth more than any individual feature on it.
May 14, 2026· 5 min